[1] 王艳苓, 张蓉. 原发性肝癌发生相关因素研究进展. 肝脏, 2016, 21:515-518. [2] 张春雨, 付宇, 李晓东,等. 肝癌的影像学诊断进展. 临床肝胆病杂志, 2017, 33:1266-1269. [3] 石颖秋. 超声造影评价原发性肝癌DSA引导下肝动脉化疗栓塞治疗的疗效. 现代肿瘤医学, 2017, 25:68-70. [4] 徐民, 程雪, 赵中伟, 等. 超声、CT、MRI及DSA在肝癌介入综合治疗术后肿瘤活性评估中的对比价值研究. 介入放射学杂志, 2018 ,27:363-366. [5] 中国抗癌协会肝癌专业委员会. 原发性肝癌规范化病理诊断指南(2015年版). 中华肝胆外科杂志, 2015, 21:865-872. [6] Sugimoto K, Shiraishi J, Tanaka H, et al. Computer-Aided diagnosis for estimating the malignancy grade of hepatocellular carcinoma using contrast-enhanced ultrasound: an ROC observer study. Liver Int, 2016, 36:1026-1032. [7] Dong Y, Wang W P, Mao F, et al. Contrast-enhanced ultrasound features of hepatocellular carcinoma not detected during the screening procedure. Z Gastroenterol, 2017, 55:748-753. [8] Terzi E, Iavarone M, Pompili M, et al. Contrast enhanced ultrasound identifies hepatocellular carcinoma in cirrhosis: a large multicenter retrospective study.. J Hepatol, 2017, 68:485-492 [9] 苏赞瑞, 黄运福, 林建军,等. 多普勒超声与肝动脉DSA联合碘油CT检查诊断微小肝癌及肝良性结节. 中国介入影像与治疗学, 2016, 13:619-622. [10] 余炎, 吕君, 余祖江,等. 四种影像学检查评价原发性肝癌患者介入治疗的疗效. 实用肝脏病杂志, 2017, 20:199-202. |